These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The apelin-APJ system in heart failure: pathophysiologic relevance and therapeutic potential. Japp AG, Newby DE. Biochem Pharmacol; 2008 May 15; 75(10):1882-92. PubMed ID: 18272138 [Abstract] [Full Text] [Related]
5. Apelin: a novel neurohumoral modulator of the cardiovascular system. Pathophysiologic importance and potential use as a therapeutic target. Falcão-Pires I, Leite-Moreira AF. Rev Port Cardiol; 2005 Oct 15; 24(10):1263-76. PubMed ID: 16398242 [Abstract] [Full Text] [Related]
6. In vivo genetic profiling and cellular localization of apelin reveals a hypoxia-sensitive, endothelial-centered pathway activated in ischemic heart failure. Sheikh AY, Chun HJ, Glassford AJ, Kundu RK, Kutschka I, Ardigo D, Hendry SL, Wagner RA, Chen MM, Ali ZA, Yue P, Huynh DT, Connolly AJ, Pelletier MP, Tsao PS, Robbins RC, Quertermous T. Am J Physiol Heart Circ Physiol; 2008 Jan 15; 294(1):H88-98. PubMed ID: 17906101 [Abstract] [Full Text] [Related]
7. Apelin and ACE2 in cardiovascular disease. Kalea AZ, Batlle D. Curr Opin Investig Drugs; 2010 Mar 15; 11(3):273-82. PubMed ID: 20178040 [Abstract] [Full Text] [Related]
15. The Emerging Potential of the Apelin-APJ System in Heart Failure. Dalzell JR, Rocchiccioli JP, Weir RA, Jackson CE, Padmanabhan N, Gardner RS, Petrie MC, McMurray JJ. J Card Fail; 2015 Jun 15; 21(6):489-98. PubMed ID: 25795508 [Abstract] [Full Text] [Related]
16. Putative role for apelin in pressure/volume homeostasis and cardiovascular disease. Charles CJ. Cardiovasc Hematol Agents Med Chem; 2007 Jan 15; 5(1):1-10. PubMed ID: 17266543 [Abstract] [Full Text] [Related]